MENU
+Compare
EDSA
Stock ticker: NASDAQ
AS OF
Sep 15, 03:20 PM (EDT)
Price
$2.40
Change
-$0.00 (-0.00%)
Capitalization
16.89M

EDSA Edesa Biotech Forecast, Technical & Fundamental Analysis

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases... Show more

EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EDSA with price predictions
Sep 12, 2025

EDSA saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for EDSA moved out of overbought territory on September 10, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 42 similar instances where the indicator exited the overbought zone. In of the 42 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EDSA moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for EDSA turned negative on September 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EDSA broke above its upper Bollinger Band on September 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on EDSA as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EDSA moved above its 50-day moving average on August 12, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for EDSA moved above the 200-day moving average on August 21, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDSA advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EDSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.440) is normal, around the industry mean (20.731). P/E Ratio (0.000) is within average values for comparable stocks, (53.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.171). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (337.655).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGI0.840.04
+5.65%
Birks Group
GOSS3.46N/A
N/A
Gossamer Bio
UAL106.58-2.78
-2.54%
United Airlines Holdings
MLCO9.60-0.36
-3.61%
Melco Resorts & Entertainment Limited
KYTX3.92-0.23
-5.54%
Kyverna Therapeutics

EDSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with DOMH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then DOMH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
-0.41%
DOMH - EDSA
37%
Loosely correlated
-5.75%
MBRX - EDSA
34%
Loosely correlated
-3.24%
TAOX - EDSA
33%
Poorly correlated
+0.81%
ORMP - EDSA
32%
Poorly correlated
-0.82%
ENTA - EDSA
32%
Poorly correlated
-4.39%
More